Decoding Idiopathic Intracranial Hypertension
Marc Bouffard discusses Mass General Brigham’s recently launched initiative aimed at better understanding idiopathic intracranial hypertension
-
By
-
Alun Evans
-
March 30, 2026
-
Clinical Scorecard: Decoding Idiopathic Intracranial Hypertension
At a Glance
| Category | Detail |
|---|
| Condition | Idiopathic Intracranial Hypertension (IIH) |
| Key Mechanisms | Glymphatic dysfunction and intracranial pressure dynamics |
| Target Population | Primarily obese women of childbearing age, but also men, children, and postmenopausal women |
| Care Setting | Neuro-ophthalmology clinics and research settings |
Key Highlights
- DTI-ALPS may serve as a noninvasive diagnostic tool for IIH.
- IIH is increasingly prevalent and often underdiagnosed.
- Current diagnostic criteria for IIH may need revision based on new findings.
- ALPS-indices show potential as a radiographic biomarker for IIH.
- Research aims to clarify mechanisms behind IIH for better treatment options.
Guideline-Based Recommendations
Diagnosis
- Utilize DTI-ALPS for noninvasive assessment of glymphatic function.
- Consider clinical diagnostic criteria alongside new biomarker findings.
Management
- Focus on understanding risk factors and pathophysiology to develop targeted interventions.
Monitoring & Follow-up
- Track ALPS-indices over time to assess disease progression and response to treatment.
Risks
- IIH primarily affects overweight women of childbearing age, but can also affect other demographics.
Patient & Prescribing Data
Obese women of childbearing age, with some cases in men and children.
Understanding glymphatic dysfunction may lead to more effective treatments.
Clinical Best Practices
- Maintain an open mind regarding evolving understandings of IIH pathophysiology.
- Consider the potential for ALPS-indices as a routine diagnostic tool.
References
